National Grid is expected to report a record first-half operating profit driven by UK electricity transmission, but UBS maintains a 'sell' rating with a price target below current share price. UBS highlights concerns over delays in National Grid's £31 billion UK transmission capital expenditure plan and questions the pace of project delivery. The bank also flags risks from National Grid's $1.75 billion investment in a Texas power project, which will not generate cash flow until the 2030s. Despite raising earnings forecasts slightly, UBS's sell rating reflects valuation concerns rather than expected earnings decline.
National Grid's £31 billion transmission plan and UBS's 'sell' rating provide context for utilities market activity. For readers following utilities, here is Pluang's market snapshot as of Oct 20, 2026 22:12 WIB: Of 40 priced US utilities stocks, 38 rose and 2 fell today. Notable movers include AEP at USD 127.25 (+2.03%, 68 days typical hold, 99% sell orders), CIG at USD 2.33 (+1.97%, 5 days typical hold), and AWR at USD 83.20 (+1.94%, 33 days typical hold, 100% buy orders).
Synchrony Financial reported Q3 2026 earnings per share of $2.68 and revenue of $4.91 billion, both exceeding analyst expectations. However, net profit fell to $892 million from $1.1 billion the previous year due to higher operating costs, even as cr...
Hancock Whitney is set to report its Q3 2026 earnings on October 20, with analysts forecasting earnings per share between $1.65 and $1.66 and revenue estimates from $418.85 million to $422 million. Despite year-over-year growth projections, indicator...
In September 2026, New York State's housing inventory increased by 9.8% year-over-year, reaching 35,294 homes available for sale. Despite this rise in supply, home prices continued to grow, with the median sales price up 5.9% to $450,000 compared to ...
The Europe Electronic Health Record (EHR) market is projected to grow from $8.05 billion in 2024 to $15.37 billion by 2031, at a compound annual growth rate of 9.9%. Growth is fueled by increasing EHR adoption, government digital health programs, and...
EssilorLuxottica reported a 9.0% increase in revenue for Q3 2026, reaching €7,486 million, with a 7.2% rise at constant exchange rates. Growth was broad-based, with strong double-digit increases in Asia-Pacific and the Direct to Consumer segment up 1...
